Drugs / Allo-MSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02509156 | Aug 2016 → Nov 2019 | cardiomyopathy due to anthracyclines | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allo-MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02509156 ↗ |
| Route | Other | “by transendocardial injection” NCT02509156 ↗ |